Conference Coverage

Self-injury and suicide ‘all too common’ in type 1 diabetes


 

FROM ADA 2022

Screening for psychological morbidities in diabetes

Guidelines from the ADA and the International Society for Pediatric and Adolescent Diabetes recommend routine screening of patients with diabetes for psychological morbidities, including depression, said Shideh Majidi, MD.

Depression is associated with higher A1c, noted Dr. Majidi, who is associate director, childhood and adolescent diabetes program at Children’s National Hospital, Washington, D.C.

She identified the following topics that need to be addressed when considering implementing a program for depression screening and suicide risk assessment in a diabetes clinic:

  • Conducting screening: Which screening questionnaire will you use? Who will do it? Where? How often?
  • Scoring screening questionnaires: Who will do it?
  • Depression screening discussion: Who will do it? How will the person be notified of the score?
  • Suicide risk assessment: Who will conduct it? What is the process to get someone to the emergency department?
  • Resources/referral: Who will initiate and follow-up?

Next steps

The RESCUE advocacy group is preparing educational and support materials for health care professionals who treat patients with diabetes, as well as other materials for patients themselves.

A version of this article first appeared on Medscape.com.

Pages

Recommended Reading

FDA clears Abbott Freestyle Libre 3 glucose sensor
MDedge Cardiology
ADA prioritizes heart failure in patients with diabetes
MDedge Cardiology
Will tirzepatide slow kidney function decline in type 2 diabetes?
MDedge Cardiology
Tirzepatide powers ‘unprecedented’ weight loss in SURMOUNT-1
MDedge Cardiology
Weekly dulaglutide promising in youth with type 2 diabetes
MDedge Cardiology
Obesity in adolescence raises risk for adult type 1 diabetes
MDedge Cardiology
Antidiabetes drug costs keep patients away
MDedge Cardiology
‘Remission is possible’ for patients with type 2 diabetes
MDedge Cardiology
Stem cell transplants could be ‘transformational’ in type 1 diabetes
MDedge Cardiology
ADA updates on finerenone, SGLT2 inhibitors, and race-based eGFR
MDedge Cardiology